PA
ARMP icon

Perceptive Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

Perceptive Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-571
Closed -$315K – 178
2016
Q1 		$315K Buy
571
+37
+7% +$19K 0.03% 142
2015
Q4 		$298K Sell
534
-37
-6% -$28.3K 0.02% 108
2015
Q3 		$316K Buy
+571
New +$522K 0.03% 117

Other funds holding ARMP

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return

Perceptive Advisors's ARMP Position: Q2 2016 in Review

Perceptive Advisors sold out of Armata Pharmaceuticals (ARMP) in Q2 2016, closing a stake of 571 shares — an estimated $315K sold.

Perceptive Advisors first reported a position in ARMP in Q3 2015 and held it in 3 quarters. The position peaked at $316K in Q3 2015. 17 funds tracked by Wall St. Rank hold ARMP as of Q2 2016.

  • Perceptive Advisors reported no remaining Armata Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Perceptive Advisors sold 571 Armata Pharmaceuticals shares in Q2 2016, an estimated $315K.
  • Perceptive Advisors first reported a position in Armata Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • Perceptive Advisors's Armata Pharmaceuticals position peaked at $316K in Q3 2015.
  • 17 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2016.

Based on Perceptive Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.